Jefferies Financial Group Weighs in on HealthEquity, Inc.’s Q1 2023 Earnings (NASDAQ:HQY)

HealthEquity, Inc. (NASDAQ:HQYGet Rating) – Investment analysts at Jefferies Financial Group upped their Q1 2023 earnings per share estimates for shares of HealthEquity in a research note issued to investors on Monday, May 9th. Jefferies Financial Group analyst G. Santangelo now anticipates that the company will earn $0.08 per share for the quarter, up from their previous estimate of $0.07. Jefferies Financial Group has a “Buy” rating and a $80.00 price target on the stock. Jefferies Financial Group also issued estimates for HealthEquity’s Q3 2023 earnings at $0.19 EPS.

A number of other brokerages have also weighed in on HQY. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $62.00 to $66.00 and gave the stock a “buy” rating in a research report on Thursday, March 24th. StockNews.com lowered shares of HealthEquity from a “hold” rating to a “sell” rating in a research report on Sunday, March 27th. BTIG Research upgraded shares of HealthEquity from a “neutral” rating to a “buy” rating and set a $85.00 price objective for the company in a research report on Wednesday, March 30th. Zacks Investment Research upgraded shares of HealthEquity from a “strong sell” rating to a “buy” rating and set a $58.00 price objective for the company in a research report on Tuesday, February 8th. Finally, Barrington Research raised their price objective on shares of HealthEquity from $55.00 to $70.00 in a research report on Wednesday, March 23rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $77.33.

Shares of NASDAQ:HQY opened at $56.80 on Tuesday. The company has a quick ratio of 2.29, a current ratio of 2.29 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $4.76 billion, a PE ratio of -107.17, a P/E/G ratio of 5.05 and a beta of 1.08. HealthEquity has a twelve month low of $36.81 and a twelve month high of $84.78. The company has a 50-day moving average price of $62.24 and a two-hundred day moving average price of $56.97.

HealthEquity (NASDAQ:HQYGet Rating) last issued its earnings results on Tuesday, March 22nd. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The firm had revenue of $203.30 million during the quarter, compared to analyst estimates of $199.27 million. HealthEquity had a negative net margin of 5.85% and a positive return on equity of 3.49%. During the same quarter last year, the business earned $0.30 earnings per share.

Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. raised its stake in shares of HealthEquity by 0.7% during the fourth quarter. BlackRock Inc. now owns 9,064,265 shares of the company’s stock worth $401,004,000 after acquiring an additional 59,190 shares in the last quarter. Wasatch Advisors Inc. raised its stake in shares of HealthEquity by 19.3% during the fourth quarter. Wasatch Advisors Inc. now owns 7,394,067 shares of the company’s stock worth $327,114,000 after acquiring an additional 1,197,807 shares in the last quarter. William Blair Investment Management LLC raised its stake in shares of HealthEquity by 1.1% during the third quarter. William Blair Investment Management LLC now owns 3,769,799 shares of the company’s stock worth $244,132,000 after acquiring an additional 42,186 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of HealthEquity by 29.5% during the fourth quarter. JPMorgan Chase & Co. now owns 2,587,846 shares of the company’s stock worth $114,487,000 after acquiring an additional 589,509 shares in the last quarter. Finally, Mackenzie Financial Corp raised its stake in shares of HealthEquity by 22.9% during the fourth quarter. Mackenzie Financial Corp now owns 2,267,898 shares of the company’s stock worth $100,332,000 after acquiring an additional 422,484 shares in the last quarter. 97.44% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile (Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Earnings History and Estimates for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.